IR
TT
CVS

WHITE TONY L

Known title: DirectorCIK: 0001171315

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Ingersoll Rand News: Growth, Earnings Outlook, and Risk Review. Recent articles highlight Ingersoll Rand’s solid growth but note that analysts have not upgraded the stock. Another piece outlines expectations for the company’s Q3 2026 earnings, while a third review praises its durable economics. A recent risk assessment lists the stock as one of two considered risky among industrials, adding a cautionary note to its profile.

this person other insiders at IR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Goldman Sachs Upgrades Trane Technologies to Buy, Raises Target. Goldman Sachs upgraded Trane Technologies to Buy and raised its price target to $565. This follows a Neutral rating from Mizuho, which set a lower target of $485. The stock is currently trading near its support level, with analysts generally viewing the company's valuation as fair given its focus on heat pumps and building efficiency.

this person other insiders at TT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.

this person other insiders at CVS

Transaction History

IR▲ Buy—
TT▼ Sell$62K
IR▲ Buy—
TT▼ Sell$35K
TT▲ Buy$0
CVS▲ Buy$4K
IR▲ Buy—
CVS▲ Buy$122K

We use analytics to understand how market-wall is used. No personal data is sold.